Chemmart Solifenacin solifenacin succinate 10 mg film coated tablets blister

Country: Awstralja

Lingwa: Ingliż

Sors: Department of Health (Therapeutic Goods Administration)

Ingredjent attiv:

solifenacin succinate, Quantity: 10 mg

Disponibbli minn:

Arrotex Pharmaceuticals Pty Ltd

INN (Isem Internazzjonali):

Solifenacin succinate

Għamla farmaċewtika:

Tablet, film coated

Kompożizzjoni:

Excipient Ingredients: lactose; titanium dioxide; croscarmellose sodium; magnesium stearate; macrogol 8000; polyvinyl alcohol; purified talc; hyprolose; iron oxide red

Rotta amministrattiva:

Oral

Unitajiet fil-pakkett:

30

Tip ta 'preskrizzjoni:

(S4) Prescription Only Medicine

Indikazzjonijiet terapewtiċi:

Solifenacin is indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency or increased urinary frequency.

Sommarju tal-prodott:

Visual Identification: Light pink coloured, round shaped, biconvex, film-coated tablets, engraved with 'APO' on one side and 'S 10' on the other side.; Container Type: Blister Pack; Container Material: PVC/Al; Container Life Time: 12 Months; Container Temperature: Store below 30 degrees Celsius

L-istatus ta 'awtorizzazzjoni:

Licence status A

Data ta 'l-awtorizzazzjoni:

2016-01-12